文献速递免疫规划传染病防控与疫情报告

吸毒人群乙型肝炎疫苗接种完成情况的预测因素:国家针对性疫苗接种项目分析

Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
PubMed 文献 · Vaccine · 2018-07-27

该研究基于荷兰2002至2011年国家疫苗接种项目登记数据,纳入18054名吸毒人群,其中15746名符合接种条件者中9089人(58%)完成三剂乙型肝炎疫苗系列接种。项目早期启动接种、年龄较大、静脉吸毒、由成瘾照护中心接种及接种地点灵活性与较高完成率相关(p<0.01)。作者认为接种地点灵活及由与吸毒人群保持可持续接触的医务人员接种可改善该风险人群的疫苗接种项目。

要点

  • 15746名符合接种条件的吸毒人群中9089人(58%)完成三剂乙型肝炎疫苗系列接种。
  • 项目早期启动接种、年龄较大、静脉吸毒、成瘾照护中心接种及接种地点灵活性与较高完成率相关(p<0.01)。
  • 作者认为接种地点灵活及由与吸毒人群保持可持续接触的医务人员接种可改善疫苗接种项目。

核心结论

  • 尽管采用标准乙型肝炎疫苗接种程序且无经济激励,吸毒人群的疫苗接种完成率相对较高。
  • 作者认为接种地点灵活及由与吸毒人群保持可持续接触的医务人员接种可改善该风险人群的疫苗接种项目。

研究设计与样本

  • 研究使用国家疫苗接种项目登记中行为风险组的数据,涉及2002至2011年间在荷兰接种乙型肝炎疫苗的吸毒人群。
  • 纳入时提供标准三剂系列(0、1、6个月),若既往或慢性HBV感染血清学标志物缺失则继续接种。
  • 以完成疫苗接种系列(至少三剂,不论时间)为因变量进行逻辑回归分析。

主要发现

  • 项目覆盖18054名吸毒人群,其中15746名符合接种条件(既非乙型肝炎携带者亦非对乙型肝炎免疫)。
  • 15746名符合接种条件者中9089人(58%)完成三剂乙型肝炎疫苗系列接种。
  • 与较高完成率相关的因素(p<0.01)包括:项目早期启动接种、吸毒者年龄较大、静脉吸毒、由成瘾照护中心接种疫苗及接种地点灵活。

关键数值与推荐

  • 完成疫苗接种系列定义为至少接种三剂,不论时间。
  • 与较高完成率相关的因素p<0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Targeted vaccination strategies are necessary to prevent people who use drugs (PWUD) becoming infected with hepatitis B virus (HBV). The aims of this study were to provide an overview of the activities for PWUD in a decentralised vaccination program in the Netherlands and to explore the determinants associated with completing a standard hepatitis B vaccination series. METHODS: We used data for behavioural risk groups from the register of the national vaccination program. The data concerned PWUD who were immunised against hepatitis B in the Netherlands between 2002 and 2011. A standard series of three vaccinations (at 0, 1, and 6 months) was offered at inclusion and was continued if serological markers for past or chronic HBV infection were absent. Completion of a vaccination series (at least three vaccinations, irrespective of timing) was a dependent variable in our logistic regression analysis. RESULTS: The program reached 18,054 PWUD. Of the 15,746 participants eligible for vaccination (i.e. they were neither carriers of hepatitis B nor immune to hepatitis B), 9089 (58%) completed a series of three hepatitis B vaccinations. Factors associated with a higher completion rate of a vaccination series (p < 0.01) were: starting vaccination in the earlier years of the program, older age of PWUD, intravenous drug use, vaccine administration by addiction care centres, and flexibility in location of vaccine delivery. CONCLUSION: Despite using a standard HBV vaccination schedule and no financial incentives, vaccination completion among PWUD was relatively high. Our results suggest that flexibility of vaccination location and administration of vaccines by healthcare workers with sustainable contact with PWUD could improve vaccination programs for this risk group.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Raven S, Urbanus A, de Gee A, et al. Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination. Vaccine. 2018. PMID: 30061025. doi:10.1016/j.vaccine.2018.07.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。